Get the SPI Wire

Wave Life Sciences, Inc.

NASDAQ:WVE
Annual Meeting

of Shareholders

MEETING DATE

11/12/2026
DEF 14A FILED
10/14/2026
PUBLISHED
10/14/2026 9:14 pm
TIME TO PUBLISH
10/16/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:WVE · CUSIP 94352A104 · CLASS common stock · CIK 0001631574

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

12
FOR
0
AGAINST
0
WITHHOLD
12
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1(a)
To elect Paul B. Bolno, M.D., MBA to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(b)
To elect Mark H.N. Corrigan, M.D. to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(c)
To elect Christian Henry to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(d)
To elect Peter Kolchinsky, Ph.D. to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(e)
To elect Adrian Rawcliffe to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(f)
To elect Ken Takanashi to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(g)
To elect Aik Na Tan to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(h)
To elect Gregory L. Verdine, Ph.D. to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
1(i)
To elect Heidi L. Wagner, J.D. to serve on the Board of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board nominated this current director for election at the 2026 ASM.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Audit Committee concluded KPMG LLP has no commercial relationship with the Company that would impair independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve a proposed amendment to our Amended and Restated 2021 Equity Incentive Plan to increase the total number of shares of common stock available for issuance thereunder by 11,000,000 shares
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states current available shares represent less than one-half of projected needs for the next year.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve, on a non-binding, advisory basis only, the compensation of our named executive officers
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The 2025 advisory vote on named executive officer compensation was supported by over 99% of votes cast.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

427ce78ccaedf02cdfea5e63c80196e31ab17b79687dac25c1f1d984e85a5b0b

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates